ATLAS: A Phase 2, Open-label Study of Rucaparib in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Clovis Oncology, Inc.
Start Date
December 11, 2018
End Date
September 30, 2020
Administered By
Duke Cancer Institute
Awarded By
Clovis Oncology, Inc.
Start Date
December 11, 2018
End Date
September 30, 2020